MD1474F1 - Method of treatment of the puerperal endometritis - Google Patents

Method of treatment of the puerperal endometritis

Info

Publication number
MD1474F1
MD1474F1 MD990076A MD990076A MD1474F1 MD 1474 F1 MD1474 F1 MD 1474F1 MD 990076 A MD990076 A MD 990076A MD 990076 A MD990076 A MD 990076A MD 1474 F1 MD1474 F1 MD 1474F1
Authority
MD
Moldova
Prior art keywords
treatment
administration
puerperal endometritis
endometritis
puerperal
Prior art date
Application number
MD990076A
Other languages
Romanian (ro)
Other versions
MD1474G2 (en
Inventor
Ludmila Etco
Isaac Sroit
Maria Carlatan
Elena Camas
Original Assignee
Univ Nicolae Testemitanu
Inst Cercetari Stiintifice
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nicolae Testemitanu, Inst Cercetari Stiintifice filed Critical Univ Nicolae Testemitanu
Priority to MD99-0076A priority Critical patent/MD1474G2/en
Publication of MD1474F1 publication Critical patent/MD1474F1/en
Publication of MD1474G2 publication Critical patent/MD1474G2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the medicine, in particular to the obstetrics and is used for treatment of puerperal endometritis. The proposed method consists in the administration of a suspension of mononuclear cells culture, obtained from the recipient blood, paracervically on the 3...6 day in the puerperium 1...3 times in a dose of 2 ml in combination with the administration of uterotonic preparations. The result of the invention consists in the immunostimulating action, reduction of the endogenic intoxication and medicamental load on the maternal organism. Claims: 1
MD99-0076A 1999-02-26 1999-02-26 Method of treatment of the puerperal endometritis MD1474G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD99-0076A MD1474G2 (en) 1999-02-26 1999-02-26 Method of treatment of the puerperal endometritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD99-0076A MD1474G2 (en) 1999-02-26 1999-02-26 Method of treatment of the puerperal endometritis

Publications (2)

Publication Number Publication Date
MD1474F1 true MD1474F1 (en) 2000-05-31
MD1474G2 MD1474G2 (en) 2000-12-31

Family

ID=19739343

Family Applications (1)

Application Number Title Priority Date Filing Date
MD99-0076A MD1474G2 (en) 1999-02-26 1999-02-26 Method of treatment of the puerperal endometritis

Country Status (1)

Country Link
MD (1) MD1474G2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2396G2 (en) * 2003-11-13 2004-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method of treatment of the chronic duodenal and recidivating postoperative ulcers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1119G2 (en) * 1998-06-22 1999-07-31 Георге КУШНИР Method for female genitals inflammatory diseases treatment

Also Published As

Publication number Publication date
MD1474G2 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
CA2149329A1 (en) Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
TW376320B (en) Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
AU3844297A (en) Treatment of autoimmune diseases
AU6649996A (en) Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
BG102343A (en) Recombinant anti-cd4 antibodies for therapy in hyman medicine
GB0001309D0 (en) Valve arrangement
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
CA2229282A1 (en) Use of hyaluronic acid as an immunosuppressant
CA2123049A1 (en) Pharmaceutical containing the p40 subunit of interleukin 12
MXPA03001673A (en) Lactic acid bacteria capable of reducing an individual s tendency to develop allergic reactions.
WO1998039034A3 (en) Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions
CA2186423A1 (en) Protein which induces interferon-gamma production by immunocompetent cell
CA2154080A1 (en) Novel anticoagulant cofactor activity
EP1002538A3 (en) Stem cell and lymphocyte storage
MD1474F1 (en) Method of treatment of the puerperal endometritis
MD1475G2 (en) Method of prophylaxis of the puerperal endometritis
MX9803610A (en) Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system.
WO1996032134A3 (en) Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body
MD1119G2 (en) Method for female genitals inflammatory diseases treatment
MD1135F1 (en) Paradontium treatment method
CA2389896A1 (en) Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation
UA5743C2 (en) Preparation of biologically active tissue substances possessing regenerative activity and method for its production
MD1137F1 (en) Method for treatment of woman sterility
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
WO2000009711A3 (en) ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)

Legal Events

Date Code Title Description
PD99 Pending application